Global Prostate Specific Antigen (PSA) Biomarker Market Insights, Forecast to 2028

Published: March 2022

No. of Pages: 108

Price:

Single User License: US $ 4900

Corporate User License: US $ 9800

Report Description
Table of Contents

Prostate Specific Antigen (PSA) Biomarker market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
- Blood
- Semen
- Urine

Segment by Application
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Others

By Company
- Abbott
- Siemens Healthcare
- DiaSorin
- Roche
- Tosoh Bioscience
- Fujirebio
- BodiTech
- GE Healthcare
- Endocare
- Quest Diagnostics
- Bio-Rad Laboratories
- QIAGEN
- Myriad RBM

By Region
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood
1.2.3 Semen
1.2.4 Urine
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Perspective (2017-2028)
2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Region
2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Region (2017-2022)
2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Region (2023-2028)
2.3 Prostate Specific Antigen (PSA) Biomarker Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Biomarker Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Biomarker Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Biomarker Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2017-2022)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2017-2022)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
3.4 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2021
3.5 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2017-2022)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2023-2028)
5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Application (2017-2022)
5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2017-2028)
6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
6.2.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
6.2.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028)
6.2.3 North America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2017-2028)
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
6.3.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
6.3.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028)
6.3.3 North America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2017-2028)
6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
6.4.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022)
6.4.2 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2017-2028)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type
7.2.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
7.2.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028)
7.2.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2017-2028)
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application
7.3.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
7.3.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028)
7.3.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2017-2028)
7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country
7.4.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022)
7.4.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size (2017-2028)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type
8.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2017-2028)
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application
8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2017-2028)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region
8.4.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size (2017-2028)
9.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type
9.2.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
9.2.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028)
9.2.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2017-2028)
9.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application
9.3.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
9.3.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028)
9.3.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2017-2028)
9.4 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country
9.4.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022)
9.4.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size (2017-2028)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type
10.2.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2017-2028)
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application
10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2017-2028)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country
10.4.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
11.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Details
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.2.5 Siemens Healthcare Recent Developments
11.3 DiaSorin
11.3.1 DiaSorin Company Details
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
11.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.3.5 DiaSorin Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Tosoh Bioscience
11.5.1 Tosoh Bioscience Company Details
11.5.2 Tosoh Bioscience Business Overview
11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
11.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.5.5 Tosoh Bioscience Recent Developments
11.6 Fujirebio
11.6.1 Fujirebio Company Details
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
11.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.6.5 Fujirebio Recent Developments
11.7 BodiTech
11.7.1 BodiTech Company Details
11.7.2 BodiTech Business Overview
11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
11.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.7.5 BodiTech Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.8.5 GE Healthcare Recent Developments
11.9 Endocare
11.9.1 Endocare Company Details
11.9.2 Endocare Business Overview
11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
11.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.9.5 Endocare Recent Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
11.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.10.5 Quest Diagnostics Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
11.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 QIAGEN
11.12.1 QIAGEN Company Details
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
11.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.12.5 QIAGEN Recent Developments
11.13 Myriad RBM
11.13.1 Myriad RBM Company Details
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
11.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
11.13.5 Myriad RBM Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Blood
Table 3. Key Players of Semen
Table 4. Key Players of Urine
Table 5. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2017-2022)
Table 9. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Region (2023-2028)
Table 11. Prostate Specific Antigen (PSA) Biomarker Market Trends
Table 12. Prostate Specific Antigen (PSA) Biomarker Market Drivers
Table 13. Prostate Specific Antigen (PSA) Biomarker Market Challenges
Table 14. Prostate Specific Antigen (PSA) Biomarker Market Restraints
Table 15. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Players (2017-2022)
Table 17. Global Top Prostate Specific Antigen (PSA) Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2021)
Table 18. Ranking of Global Top Prostate Specific Antigen (PSA) Biomarker Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
Table 22. Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2017-2022)
Table 26. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2023-2028)
Table 28. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Application (2017-2022)
Table 30. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Application (2023-2028)
Table 32. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Prostate Specific Antigen (PSA) Biomarker Product
Table 65. Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 66. Abbott Recent Developments
Table 67. Siemens Healthcare Company Details
Table 68. Siemens Healthcare Business Overview
Table 69. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product
Table 70. Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 71. Siemens Healthcare Recent Developments
Table 72. DiaSorin Company Details
Table 73. DiaSorin Business Overview
Table 74. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product
Table 75. DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 76. DiaSorin Recent Developments
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Prostate Specific Antigen (PSA) Biomarker Product
Table 80. Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 81. Roche Recent Developments
Table 82. Tosoh Bioscience Company Details
Table 83. Tosoh Bioscience Business Overview
Table 84. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product
Table 85. Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 86. Tosoh Bioscience Recent Developments
Table 87. Fujirebio Company Details
Table 88. Fujirebio Business Overview
Table 89. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product
Table 90. Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 91. Fujirebio Recent Developments
Table 92. BodiTech Company Details
Table 93. BodiTech Business Overview
Table 94. BodiTech Prostate Specific Antigen (PSA) Biomarker Product
Table 95. BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 96. BodiTech Recent Developments
Table 97. GE Healthcare Company Details
Table 98. GE Healthcare Business Overview
Table 99. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product
Table 100. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 101. GE Healthcare Recent Developments
Table 102. Endocare Company Details
Table 103. Endocare Business Overview
Table 104. Endocare Prostate Specific Antigen (PSA) Biomarker Product
Table 105. Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 106. Endocare Recent Developments
Table 107. Quest Diagnostics Company Details
Table 108. Quest Diagnostics Business Overview
Table 109. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product
Table 110. Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 111. Quest Diagnostics Recent Developments
Table 112. Bio-Rad Laboratories Company Details
Table 113. Bio-Rad Laboratories Business Overview
Table 114. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product
Table 115. Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 116. Bio-Rad Laboratories Recent Developments
Table 117. QIAGEN Company Details
Table 118. QIAGEN Business Overview
Table 119. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product
Table 120. QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 121. QIAGEN Recent Developments
Table 122. Myriad RBM Company Details
Table 123. Myriad RBM Business Overview
Table 124. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product
Table 125. Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022) & (US$ Million)
Table 126. Myriad RBM Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Type: 2021 VS 2028
Figure 2. Blood Features
Figure 3. Semen Features
Figure 4. Urine Features
Figure 5. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2021 VS 2028
Figure 6. Diagnostics Case Studies
Figure 7. Drug Discovery Case Studies
Figure 8. Personalized Medicine Case Studies
Figure 9. Others Case Studies
Figure 10. Prostate Specific Antigen (PSA) Biomarker Report Years Considered
Figure 11. Global Prostate Specific Antigen (PSA) Biomarker Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Region: 2021 VS 2028
Figure 14. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players in 2021
Figure 15. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue in 2021
Figure 17. North America Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2028)
Figure 19. North America Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2028)
Figure 20. North America Prostate Specific Antigen (PSA) Biomarker Market Size Share by Country (2017-2028)
Figure 21. United States Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2028)
Figure 25. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2028)
Figure 26. Europe Prostate Specific Antigen (PSA) Biomarker Market Size Share by Country (2017-2028)
Figure 27. Germany Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Prostate Specific Antigen (PSA) Biomarker Market Size Share by Region (2017-2028)
Figure 37. China Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Prostate Specific Antigen (PSA) Biomarker Market Size Share by Country (2017-2028)
Figure 47. Mexico Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Prostate Specific Antigen (PSA) Biomarker Market Size Share by Country (2017-2028)
Figure 53. Turkey Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 57. Siemens Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 58. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 59. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 60. Tosoh Bioscience Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 61. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 62. BodiTech Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 63. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 64. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)
Figure 65. Quest Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2017-2022)

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group1659924

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Prostate-Specific Antigen (PSA) Test Market Insights and Forecast to 2028 Prostate-Specific Antigen (PSA) Test market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate-Specific Antigen (PSA) Test market will be able to gain the upper ...
Global Prostate-specific Antigen (PSA) Testing Market Insights, Forecast to 2028 Prostate-specific Antigen (PSA) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the ...
Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Insights, Forecast to 2028 Prostate Specific Antigen (PSA) Blood Based Biomarker market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Blood Based Biomarker mark...
Global Prostate Specific Antigen (PSA) Testing Market Research Report 2022 Prostate Specific Antigen (PSA) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Testing market will be able to gain the ...
Global Prostate-Specific Antigen (PSA) Test Market Size, Status and Forecast 2021-2027 Market Analysis and Insights: Global Prostate-Specific Antigen (PSA) Test Market The global Prostate-Specific Antigen (PSA) Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202...
Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Research Report 2021, Forecast to 2026 The report forecast global Prostate Specific Antigen (PSA) Blood Based Biomarker market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dolla...
Global Prostate Specific Antigen (PSA) Blood Based Biomarker Professional Survey Report 2021, Forecast to 2026 The report forecast global Prostate Specific Antigen (PSA) Blood Based Biomarker market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dolla...
Global Prostate Specific Antigen (PSA) Biomarker Market Status and Outlook 2021-2026 The report forecast global Prostate Specific Antigen (PSA) Biomarker market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjust...
Prostate Specific Antigen (PSA) Biomarker Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global M...
Prostate Specific Antigen (PSA) Blood Based Biomarker Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global M...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

We're Here To Help You

Request for Sample of this report